Aging in fragile X syndrome

FMR1: A gene with three faces

(2009) Ben A Oostra et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

mTOR Signal and Hypoxia-Inducible Factor-1  Regulate CD133 Expression in Cancer Cells

(2009) K. Matsumoto et al.   CANCER RESEARCH

Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone

(2009) Michael P. Caligiuri et al.   HUMAN MOVEMENT SCIENCE

Reduction in Neuroleptic-Induced Movement Disorders After a Switch to Quetiapine in Patients With Schizophrenia

(2009) Leonardo Cortese et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Screening for Expanded Alleles of the FMR1 Gene in Blood Spots from Newborn Males in a Spanish Population

(2009) Isabel Fernandez-Carvajal et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Cognitive decline in Parkinson’s disease: A prospective longitudinal study

(2009) DINO MUSLIMOVIĆ et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Origins of Epilepsy in Fragile X Syndrome

(2009) Paul J. Hagerman et al.   Epilepsy Currents

Expanded clinical phenotype of women with theFMR1 premutation

(2008) Sarah M. Coffey et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004

(2008) Jeffrey A. Cutler et al.   HYPERTENSION

FMRP Acts as a Key Messenger for Dopamine Modulation in the Forebrain

(2008) Hansen Wang et al.   NEURON

Advances in the Treatment of Fragile X Syndrome

(2008) R. J. Hagerman et al.   PEDIATRICS